IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jun 28, 2007
Insider Transaction Report
Form 4
WYNGAARDEN JAMES B
Director
Transactions
- Award
Stock Options
2007-07-01+1,250→ 1,250 totalFrom: 2008-07-01Exp: 2017-07-01→ Common Stock (1,250 underlying)
Footnotes (1)
- [F1]The exercise price will be determined at the end of business on June 29, 2007.